Barbara Shepherd

798 total citations
7 papers, 382 citations indexed

About

Barbara Shepherd is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Barbara Shepherd has authored 7 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Barbara Shepherd's work include Tuberculosis Research and Epidemiology (3 papers), RNA Research and Splicing (3 papers) and vaccines and immunoinformatics approaches (2 papers). Barbara Shepherd is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), RNA Research and Splicing (3 papers) and vaccines and immunoinformatics approaches (2 papers). Barbara Shepherd collaborates with scholars based in United States, Netherlands and Denmark. Barbara Shepherd's co-authors include Pieter C. Wensink, Michael J. Garabedian, David Finnegan, Philip N. Tsichlis, S E Bear, David A. Hokey, Søren T. Hoff, Peter Andersen, Ingrid Kromann and Mien‐Chie Hung and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Molecular Biology.

In The Last Decade

Barbara Shepherd

7 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Shepherd United States	7	226	135	111	102	62	7	382
Adrian Creanga United States	8	343 1.5×	76 0.6×	64 0.6×	71 0.7×	40 0.6×	12	510
Allison K. Timmons United States	12	185 0.8×	181 1.3×	48 0.4×	35 0.3×	60 1.0×	14	438
Claire L. Hill United Kingdom	7	250 1.1×	28 0.2×	75 0.7×	95 0.9×	19 0.3×	7	443
Melissa Reynolds United States	8	200 0.9×	53 0.4×	34 0.3×	87 0.9×	44 0.7×	9	428
Kasandra Bélanger Canada	9	200 0.9×	89 0.7×	57 0.5×	36 0.4×	13 0.2×	15	387
Winfrid Liebrich Germany	9	151 0.7×	164 1.2×	16 0.1×	138 1.4×	27 0.4×	16	367
J. Huang China	7	228 1.0×	53 0.4×	62 0.6×	96 0.9×	30 0.5×	12	483
Julia Gilden United States	7	237 1.0×	84 0.6×	59 0.5×	16 0.2×	40 0.6×	11	460
Thomas R. Davis United States	11	649 2.9×	111 0.8×	26 0.2×	142 1.4×	42 0.7×	13	738
Kartik Soni India	7	369 1.6×	71 0.5×	45 0.4×	35 0.3×	15 0.2×	16	508

Countries citing papers authored by Barbara Shepherd

Since Specialization

Citations

This map shows the geographic impact of Barbara Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Shepherd more than expected).

Fields of papers citing papers by Barbara Shepherd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Shepherd. The network helps show where Barbara Shepherd may publish in the future.

Co-authorship network of co-authors of Barbara Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Shepherd. A scholar is included among the top collaborators of Barbara Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Shepherd. Barbara Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Suliman, Sara, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.. (2018). Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial. American Journal of Respiratory and Critical Care Medicine. 199(2). 220–231. 76 indexed citations

Vesikari, Timo, Markus Maeurer, Raija Ahmed, et al.. (2017). Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials. Vaccine. 35(12). 1652–1661. 41 indexed citations

Walsh, Douglas S., Mark E. Polhemus, Lucas Otieno, et al.. (2016). Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis. Vaccine. 34(21). 2430–2436. 9 indexed citations

Tsichlis, Philip N., Barbara Shepherd, & S E Bear. (1989). Activation of the Mlvi-1/mis1/pvt-1 locus in Moloney murine leukemia virus-induced T-cell lymphomas.. Proceedings of the National Academy of Sciences. 86(14). 5487–5491. 28 indexed citations

Garabedian, Michael J., Barbara Shepherd, & Pieter C. Wensink. (1986). A tissue-specific transcription enhancer from the Drosophila yolk protein 1 gene. Cell. 45(6). 859–867. 172 indexed citations

Shepherd, Barbara, Michael J. Garabedian, Mien‐Chie Hung, & Pieter C. Wensink. (1985). Developmental Control of Drosophila Yolk Protein 1 Gene by cis-acting DNA Elements. Cold Spring Harbor Symposia on Quantitative Biology. 50(0). 521–526. 24 indexed citations

Shepherd, Barbara & David Finnegan. (1984). Structure of circular copies of the 412 transposable element present in Drosophila melanogaster tissue culture cells, and isolation of a free 412 long terminal repeat. Journal of Molecular Biology. 180(1). 21–40. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact